Navigation Links
Endo Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 1, 2010
Date:10/20/2010

CHADDS FORD, Pa., Oct. 20 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its third quarter 2010 financial results on November 1, 2010 and will host a conference call and webcast at 10:00 a.m. ET that day to discuss these results.  

David P. Holveck, president and CEO of Endo, Julie McHugh, chief operating officer, Dr. Ivan Gergel, executive vice president of R&D, Alan Levin, executive vice president and chief financial officer and Blaine Davis, vice president, corporate affairs will host the call.

Investors and other interested parties may call 866-788-0543 (domestic) or 857-350-1681 (international) and enter passcode 81013739.  Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from November 1 at 1:00 p.m. ET until 12:00 a.m. ET on November 9 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering passcode 88788586.

A simultaneous webcast of the call may be accessed by visiting www.endo.com.  In addition, a replay of the webcast will be available until 12:00 a.m. ET on November 9.  The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo

Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company, focused on high-value branded products and specialty generics. Endo is redefining its position in the healthcare marketplace by anticipating and embracing the evolution of health decisions based on the need for high-quality and cost-effective care. We aim to be the premier partner to healthcare professionals and payment providers, delivering an innovative suite of complementary diagnostics, drugs, devices and clinical data to meet the needs of patients in areas such as pain, urology, oncology and endocrinology
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Quark Pharmaceuticals Doses First Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Patient in Stratum II of its Clinical Study of siRNA Drug Candidate QPI-1007
2. MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress
3. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
4. Inspiration Biopharmaceuticals OBI-1 Receives Orphan Drug Designation in Europe
5. Keryx Biopharmaceuticals to Present at BioCenturys NewsMakers in the Biotech Industry Conference
6. Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study
7. Transcept Pharmaceuticals to Host Conference Call to Discuss Preliminary Analysis of Intermezzo® Highway Driving Study
8. Transcept Pharmaceuticals to Present at Newsmakers in the Biotech Industry Conference
9. Sagent Pharmaceuticals Announces Launch of ANEclear Device for Rapid Clearance of Inhaled Anesthetics Following Surgery
10. Excaliard Pharmaceuticals Appoints Thomas Wiggans to Chairman of the Board
11. ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... CHICAGO , July 29, 2014  Roche (SIX: ... American Association for Clinical Chemistry (AACC) 2014 Clinical Lab ... focused on the unique ways Roche is partnering with ... "Our customers tell us every day that they,re ... value they deliver in their labs and offices," said ...
(Date:7/29/2014)... and TORONTO , ... Corporation (OTCBB: ESAQ), an emerging pharmaceutical company ... of improved novel formulations and alternative dosage ... expansion of its pharmaceutical development implementing its sub-micron ... large molecule drugs that will address indications ...
(Date:7/29/2014)... July 29, 2014 Cynosure, Inc. ... laser- and light-based aesthetic treatment systems for high-volume applications, ... June 30, 2014. Second-quarter 2014 financial results incorporate the ... June 24, 2013. Second-Quarter 2014 ... 45% to $72.6 million , Non-GAAP net income ...
Breaking Medicine Technology:Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 2EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 3EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 4Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12
... 2011 Luminex Corporation (Nasdaq: LMNX ) ... 2011 Global Healthcare Conference to be held June 6-9 ... The investor presentation by Patrick J. ... 9:00 a.m. Eastern time on Tuesday, June 7, 2011.  The ...
... MALVERN, Pa., May 31, 2011 Fujirebio Diagnostics, ... (FDA) has granted 510 (k) clearance to the CYFRA 21-1™ ... disease and treatment of lung cancer patients. This is the ... use in the management of patients with lung cancer. ...
Cached Medicine Technology:Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference 2Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer 2
(Date:7/29/2014)... Winter is here down under, and it ... central business district. That is, until a troop of ... otherwise ordinary day into a celebration—a celebration of drug-free ... of The Truth About Drugs, a drug prevention initiative ... woke up the city with a rousing performance of ...
(Date:7/29/2014)... July 29, 2014 DailyGossip.org reveals in its ... by someone who can perfectly understand patients and what they ... , Ellie Gadsby is the author of the new program. ... After years of suffering, Ellie started her very own research. ... remedies. , The author of the Get Rid of Cold ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Regardless of ... needs a special someone to share those with. Love ... special someone. , Love is also about overcoming ... However, to have that perfect relationship, women need to ... more about the Enchant Him program, please visit the ...
(Date:7/29/2014)... 2014 (HealthDay News) -- Want young children to embrace ... that,s healthy is good for them. Doing so will ... new study suggests. "Parents and caregivers who are ... better off simply serving the food without saying anything ... food actually is," said study authors Michal Maimaran, of ...
(Date:7/29/2014)... Advertising claims for cosmetic procedures using stem cells are ... and effectiveness, according to a review in the August ... , the official medical journal of the American ... offer tremendous potential, but the marketplace is saturated with ... at risk," write Dr Michael T. Longaker of Stanford ...
Breaking Medicine News(10 mins):Health News:Sydney Business District “Rocked” by The Truth About Drugs 2Health News:Get Rid of Cold Sores Fast Review Exposes the Way to Stop Outbreaks 2Health News:How to Reach the Heart of the Perfect Guy with "Enchant Him Program" - a Report by Daily Gossip Magazine 2Health News:Kids Will Pass on 'Healthy' Foods 2Health News:Beware of claims about cosmetic stem cells procedures, says review in Plastic and Reconstructive Surgery 2
... WASHINGTON, Nov. 12 U.S. ... Assurance (NCQA) today released the fifth annual edition of ... . Published at the start of open-enrollment season, ... the 2009-10 Best Health Insurance Plans guide provides consumers ...
... Mary Elizabeth Derig, of Seattle, Washington, has been ... her outstanding contributions and achievements in the field of ... ) , ABOUT MARY ELIZABETH DERIG ... career as a Registered Nurse including work in post ...
... 12 Satellite Healthcare, one of the nation,s first and ... of nephrology research, today announced the opening of a new ... to Satellite Healthcare,s rapidly expanding presence in the central valley, ... those affected with Chronic Kidney Disease (CKD). , "This new ...
... growth of cancer cells in lab study , THURSDAY, Nov. ... form of leukemia holds promise as a possible treatment for ... (Sprycel) is used to treat chronic myeloid leukemia. Researchers at ... drug limited the growth and invasive powers of ovarian cancer ...
... ... Drive stepper motor linear actuator. The IDEA Drive is an integrated linear actuator, electronic ... Interface). , ... November 13, 2009 -- Haydon Kerk Motion Solutions introduces the Haydon IDEA™ Drive stepper ...
... ... simple holiday recipe for Holly Jolly Biscotti, which showcases the peak-season flavors of Texas citrus ... way to promote a good-for-you diet throughout the holidays not just for yourself, but everyone ... ...
Cached Medicine News:Health News:U.S. News Media Group and NCQA Release 2009-10 Rankings of America's Best Health Insurance Plans 2Health News:U.S. News Media Group and NCQA Release 2009-10 Rankings of America's Best Health Insurance Plans 3Health News:U.S. News Media Group and NCQA Release 2009-10 Rankings of America's Best Health Insurance Plans 4Health News:Mary Elizabeth Derig Recognized by Strathmore's Who's Who Worldwide Publication 2Health News:Satellite Dialysis Celebrates the Opening of Its Newest Center in Tracy, CA 2Health News:Leukemia Drug May Help Some Ovarian Cancer Patients 2Health News:Haydon Kerk Motion Solutions Introduces the IDEA Drive 2Health News:Dip into a Healthy Holiday with the Taste of Texas Oncology's Holly Jolly Biscotti 2Health News:Dip into a Healthy Holiday with the Taste of Texas Oncology's Holly Jolly Biscotti 3Health News:Dip into a Healthy Holiday with the Taste of Texas Oncology's Holly Jolly Biscotti 4
... INTERING Vascular Graft, the newest vascular graft ... a leader in vascular surgical products for ... by reducing kinking and compression problems ... new graft provides all of the benefits ...
... Vikingselect Intra-Operative Monitoring (IOM). ... the brain and nervous system. Time-stamped ... and amplitudes. Quick visual overview of ... trendplots on-line. Special software allows simultaneous ...
... especially designed for surgical monitoring and Intensive ... and is equipped with two headboxes and ... be independently configured as either a true ... amplifiers are based on the Firewire (IEEE1394TM) ...
... management software - was designed by ... improvement tool helps diabetes care providers ... bridges medicine with technology by providing ... information technology product. This diabetes ...
Medicine Products: